PEMPFIX - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 79212465
Serial Number
79212465
Registration Number
5440650
Word Mark
PEMPFIX
Status
700 - Registered
Status Date
2018-04-10
Filing Date
2016-06-02
Registration Number
5440650
Registration Date
2018-04-10
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2018-01-23
Law Office Assigned Location Code
M30
Employee Name
TOOLEY, DAVID E
Statements
Goods and Services
Pharmaceutical and biochemical pharmaceutical preparations for the treatment of or prevention against inflammatory diseases, cancer, infectious diseases, fungal diseases, diseases caused by parasites, eye diseases, diseases of the central and peripheral nervous systems, cardiovascular diseases, diseases affecting the immune system, genetic diseases, single gene disorders, mouth, teeth, skin, hair and ear diseases, bone and blood diseases as well as reproductive system diseases; pharmaceutical and biochemical pharmaceutical preparations for contraception; biochemical and chemical pharamceuticals preparations for use with inflammatory diseases, in particular for use with chronic and autoimmune inflammatory diseases; biochemical and chemical pharmaceuticals preparations for prevention against inflammatory diseases, in particular for prevention against chronic and autoimmune inflammatory diseases; biochemical and chemical pharmaceuticals preparations for prevention against chronic and autoimmune inflammatory skin diseases; biochemical and chemical products for prevention against psoriasis, lupus erythematodes; biochemical and chemical pharmaceuticals preparations for prevention against blister-forming autoimmune dermatoses; biochemical and chemical pharmaceuticals preparations for prevention against pemphigus diseases; biochemical and chemical pharmaceuticals preparations for prevention against pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus; biochemical and chemical pharmaceuticals preparations for prevention against subepidermal bullous autoimmune dermatoses; biochemical and chemical pharmaceuticals preparations for prevention against bullous pemphigoid, pemphigoid gestationis, linear IgA dermatosis, mucosal pemphigoid, lichen planus pemphigoide, anti-laminin gamal/p200 pemphigoid, epidermolysis bullosa acquisita, dermatitis herpetiformis, in particular against bullous pemphigoid; biochemical and chemical pharmaceuticals preparations for prevention against chronic and autoimmune inflammatory diseases of the central nervous systems, in particular for prevention against multiple sclerosis; biochemical and chemical pharmaceuticals preparations for the treatment of inflammatory diseases, in particular for the treatment of chronic and autoimmune inflammatory diseases; biochemical and chemical pharmaceuticals preparations for the treatment of chronic and autoimmune inflammatory skin diseases, in particular for the treatment of psoriasis, lupus erythematodes; biochemical and chemical pharmaceuticals preparations for the treatment of blister-forming autoimmune dermatoses; biochemical and chemical pharmaceuticals preparations for the treatment of pemphigus diseases; biochemical and chemical pharmaceuticals preparations for the treatment of pemphigus vulgaris, pemphigus foliaceus, paraneoplastic pemphigus; biochemical and chemical pharmaceutical preparations for the treatment of subepidermal bullae autoimmune dermatoses; biochemical and chemical pharmaceuticals preparations for the treatment of bullous pemphigoid, pemphigoid gestationis, linear IgA dermatosis, mucosal pemphigoid, lichen planus pemphigoid, anti-laminin gamal/p200 pemphigoid, epidermolysis bullosa acquisita, dermatitis herpetiformis, in particular against bullous pemphigoid; biochemical and chemical pharmaceuticals preparations for the treatment of chronic and autoimmune inflammatory diseases of the central nervous system, in particular for the treatment of multiple sclerosis; topical and transdermal pharmaceuticals, in particular creams, dispersions, lotions, ointments, fluids, solutions, sprays, plasters, lacquer and filmforming solutions, for the prevention and treatment of skin diseases of the uppermost skin layer or the upper skin layers; surface treatment pharmaceuticals preparations for use as treatments of immune system diseases, inflammatory diseases, skin, hair and ear diseases; oral administration pharmaceuticals preparations, in particular pills, tablets, lozenges, capsules, liquids, solutions, drops, for the prevention and treatment of central nervous system diseases
Translation of Words in Mark
The word(s) "PEMPIX" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-07-19
Primary Code
005
Current Trademark Owners
Party Name
Novalis Investments S.L.
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Novalis Investments S.L.
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Immungenetics AG
Party Type
30 - Original Registrant
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Party Name
Immungenetics AG
Party Type
20 - Owner at Publication
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Party Name
Immungenetics AG
Party Type
10 - Original Applicant
Legal Entity Type
25
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Antonio Martinez
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1356004
International Registration Date
2016-06-02
International Publication Date
2017-07-13
International Renewal Date
2026-06-02
Auto Protection Date
2019-01-13
International Status
001 - Request for extension of protection established
International Status Date
2017-07-13
Priority Claimed In
True
Priority Claimed Date
2016-01-26
First Refusal In
True
Trademark Events
Event DateEvent Description
2017-07-13SN ASSIGNED FOR SECT 66A APPL FROM IB
2017-07-19NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-07-19ASSIGNED TO EXAMINER
2017-07-25APPLICATION FILING RECEIPT MAILED
2017-07-31NON-FINAL ACTION WRITTEN
2017-08-01NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
2017-08-01REFUSAL PROCESSED BY MPU
2017-08-01NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
2017-08-18REFUSAL PROCESSED BY IB
2017-11-08TEAS RESPONSE TO OFFICE ACTION RECEIVED
2017-11-19ASSIGNED TO LIE
2017-11-27CORRESPONDENCE RECEIVED IN LAW OFFICE
2017-11-27TEAS/EMAIL CORRESPONDENCE ENTERED
2017-12-19APPROVED FOR PUB - PRINCIPAL REGISTER
2018-01-03NOTICE OF PUBLICATION
2018-01-03NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
2018-01-03NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
2018-01-19NOTIFICATION PROCESSED BY IB
2018-01-23PUBLISHED FOR OPPOSITION
2018-02-21TEAS CHANGE OF CORRESPONDENCE RECEIVED
2018-04-10REGISTERED-PRINCIPAL REGISTER
2018-07-10FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
2018-07-30FINAL DISPOSITION PROCESSED
2018-07-30FINAL DISPOSITION NOTICE SENT TO IB
2018-08-24FINAL DECISION TRANSACTION PROCESSED BY IB
2019-07-26NEW REPRESENTATIVE AT IB RECEIVED
2020-04-30CHANGE OF OWNER RECEIVED FROM IB
2021-07-30NEW REPRESENTATIVE AT IB RECEIVED